In the context of virus infection, Gefitinib showed no effect on PLC-γ1 steady-state protein expression at any time point examined (Figure 6E–H), suggesting that the decreased PLC-γ1(S1248) levels by Gefitinib were not due to the reduction of total PLC-γ1 expression. The gene discussed is PLCG1; the disease is viral infectious disease.